Year |
Citation |
Score |
2019 |
Das A, Merrill P, Wilson J, Turner T, Paige M, Capitosti S, Brown M, Freshcorn B, Sok MCP, Song H, Botchwey EA. Evaluating Angiogenic Potential of Small Molecules Using Genetic Network Approaches. Regenerative Engineering and Translational Medicine. 5: 30-41. PMID 31008183 DOI: 10.1007/s40883-018-0077-8 |
0.438 |
|
2007 |
Chruszcz M, Chinigo GM, Capitosti SM, Brown ML, Minor W. 2-(Biphenyl-4-yl)-2,3-dihydroquinazolin-4(1H)-one Acta Crystallographica Section E: Structure Reports Online. 63: o891-o893. DOI: 10.1107/S1600536807002103 |
0.5 |
|
2006 |
Wieghaus KA, Capitosti SM, Anderson CR, Price RJ, Blackman BR, Brown ML, Botchwey EA. Small molecule inducers of angiogenesis for tissue engineering. Tissue Engineering. 12: 1903-13. PMID 16889520 DOI: 10.1089/Ten.2006.12.1903 |
0.523 |
|
2005 |
Wieghaus KA, Capitosti SM, Brown ML, Botchwey EA. Novel angiogenic compounds for targeted drug delivery Materials Research Society Symposium Proceedings. 845: 357-361. DOI: 10.1557/Proc-845-Aa5.47 |
0.506 |
|
2005 |
Wieghaus KA, Capitosti SM, Brown ML, Botchwey EA. Small molecule stimulators of angiogenesis for bone tissue engineering Proceedings of the 2005 Summer Bioengineering Conference. 2005: 1182-1183. |
0.373 |
|
2004 |
Brennen WN, Cooper CR, Capitosti S, Brown ML, Sikes RA. Thalidomide and analogues: current proposed mechanisms and therapeutic usage. Clinical Prostate Cancer. 3: 54-61. PMID 15279692 DOI: 10.3816/Cgc.2004.N.014 |
0.453 |
|
2004 |
Capitosti SM, Hansen TP, Brown ML. Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer. Bioorganic & Medicinal Chemistry. 12: 327-36. PMID 14723953 DOI: 10.1016/J.Bmc.2003.11.007 |
0.575 |
|
2003 |
Capitosti SM, Hansen TP, Brown ML. Facile synthesis of an azido-labeled thalidomide analogue. Organic Letters. 5: 2865-7. PMID 12889894 DOI: 10.1021/Ol034906W |
0.558 |
|
Show low-probability matches. |